Hanmi Pharmaceutical Unveils Next-Generation Modalities, Debuts Innovative Targeted Anticancer Drug

Hanmi Pharmaceutical, the core business subsidiary of Hanmi Science, unveiled a range of next-generation modality research achievements at a ...
Law

Utah Supreme Court Approves Alternate Pathway to Bar

“This is not about making it easier to become a lawyer,” Utah Supreme Court Associate Chief Justice, and Working Group Chair, John A. Pearce, said in a statement. “It’s about making it smarter.” Utah ...
C&EN

Exploring Phosphatase and Tensin Homologue Deleted on Chromosome Ten (PTEN) as a Potential Therapeutic Target for Cardiac Hypertrophy

While cardiovascular diseases continue to be the foremost cause of death worldwide, heart failure constitutes a major segment responsible for these mortalities. Heart failure results from exhausted ...
oncnursingnews

Genomic Changes May Drive Sotorasib KRAS G12C+ Combo Resistance in CRC

Biomarker data from CodeBreaK 300 suggest DNA and RTK pathway alterations may underlie resistance to sotorasib plus panitumumab in CRC. Overall, 49.2% of patients who received sotorasib/panitumumab ...
ascopubs.org

New Treatment Approaches for Triple-Negative Breast Cancer

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Triple-negative breast cancer (TNBC) was first described as a distinct disease ...
Targeted Oncology

Epigenetic and Genomic Changes May Drive Resistance to Sotorasib Combo in KRAS G12C CRC

DNA methylation, RTK pathway changes, and KRAS amplifications may drive resistance to sotorasib plus panitumumab in KRAS G12C colorectal cancer. Emerging biomarker data from the phase 3 CodeBreaK 300 ...
Electronic Design

How RTK Can Help Autonomous Vehicles See the World

Why precision location estimates are crucial for autonomous vehicles. How autonomous vehicles rely on various components of a complex tech stack to understand their place in the world and navigate ...